Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cross-sectional Study on the Prevalence of GERD in Primary Care Patients With Upper GI Symptoms Using the GERD-Q. The Bulgarian GERD-Q Study

NCT01020890 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01020890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01020890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cross-sectional Study on the Prevalence of GERD in Primary Care Patients With Upper GI Symptoms Using the GERD-Q. The Bulgarian GERD-Q Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 30, 2009
Completion date
April 30, 2010
Enrollment
2,210 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease